abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
No open-market purchases or sales by abrdn Life Sciences Investors insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $156.8M in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports abrdn Life Sciences Investors filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
| Filed | Form | 8-K items | Period | Document | Filing index |
|---|---|---|---|---|---|
| Sep 12, 2023 | 8-K | 4.019.01 | Sep 6, 2023 | SEC | Index |
| Mar 25, 2013 | 8-K | 8.019.01 | Mar 22, 2013 | SEC | Index |
| Mar 23, 2012 | 8-K | 8.019.01 | Mar 23, 2012 | SEC | Index |
| Jun 30, 2011 | 8-K | 8.019.01 | Jun 30, 2011 | SEC | Index |
| May 3, 2011 | 8-K | 8.019.01 | May 2, 2011 | SEC | Index |
| Nov 2, 2010 | 8-K | 8.019.01 | Nov 1, 2010 | SEC | Index |
| Apr 6, 2010 | 8-K | 8.019.01 | Apr 5, 2010 | SEC | Index |
| Sep 30, 2009 | 8-K | 8.019.01 | Sep 30, 2009 | SEC | Index |
| Aug 4, 2009 | 8-K | 8.019.01 | Aug 4, 2009 | SEC | Index |